| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |